{"DataElement":{"publicId":"2002244","version":"3","preferredName":"Bevacizumab Agent Quantity Dose","preferredDefinition":"the quantity of a monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.","longName":"BEV_AGT_QUANT_DS","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2011694","version":"3","preferredName":"Bevacizumab Agent Quantity","preferredDefinition":"information related to amount of a monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.","longName":"BEV_AGT_QUANT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2469555","version":"1","preferredName":"Bevacizumab Agent","preferredDefinition":"A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C2039:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bevacizumab","conceptCode":"C2039","definition":"A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10B1EB25-0AFE-58ED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-04-05","modifiedBy":"ONEDATA","dateModified":"2006-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2440114","version":"1","preferredName":"Quantity","preferredDefinition":"Quantity; how much there is of something that you can measure.","longName":"C25256","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quantity","conceptCode":"C25256","definition":"How much there is of something that you can measure; the total amount or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08704E62-EF89-4DBA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-25","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-12-25","modifiedBy":"ONEDATA","dateModified":"2005-12-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A16F7641-8424-5E6A-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-05-20","endDate":null,"createdBy":"JASUR","dateCreated":"2002-05-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"ISO compliance - Lung Change Management 08/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018364","version":"1","preferredName":"Agent Dose","preferredDefinition":"the quantity of an agent or drug.","longName":"AGT_DOSE","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207920","version":"1","preferredName":"Agent Dose","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI):The amount of medicine taken, or radiation given, at one time.","longName":"C1708:C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-353A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30B69FB-0019-1190-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"ALAIS","dateModified":"2007-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Bevacizumab dose (mg)","url":null,"context":"CTEP"},{"name":"Bevacizumab dose (mg)","type":"Preferred Question Text","description":"Bevacizumab dose (mg)","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A16F7641-8425-5E6A-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-05-20","endDate":null,"createdBy":"JASUR","dateCreated":"2002-05-20","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":"ISO compliance -Lung Change Management 08/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}